REFERENCES
- Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nature reviews. Genetics 2002;3:662–673.
- Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nature reviews. Genetics 2008;9:465–476.
- Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nature reviews. Cancer 2006;6:107–116.
- Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683–692.
- Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395–2402.
- Bird AP, Wolffe AP. Methylation-induced repression–belts, braces, and chromatin. Cell 1999;99:451–454.
- Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089–1093.
- Xu F, Mao C, Ding Y, et al. Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs. Curr Med Chem 2010;17:4052–4071.
- Kim MS, Kim YR, Yoo NJ, et al. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. APMIS 2013;121:85–94.
- He S, Wang F, Yang L, et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PloS One 2011;6:e27684.
- Rahman MM, Qian ZR, Wang EL, et al. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors. Hum Pathol 2010;41:1069–1078.
- Cao XY, Jia ZF, Cao DH, et al. DNMT3a rs1550117 polymorphism association with increased risk of Helicobacter pylori infection. Asian Pac J Cancer Prev 2013;14:5713–5718.
- Chung CJ, Chang CH, Liu CS, et al. Association of DNA Methyltransferases 3A and 3B Polymorphisms, and Plasma Folate Levels with the Risk of Urothelial Carcinoma. PloS One 2014;9:e104968.
- Fan H, Liu D, Qiu X, et al. A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma. BMC Med 2010;8:12.
- Mostowska A, Sajdak S, Pawlik P, et al. DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population. Mol Biol Rep 2013;40:4893–4899.
- Sun MY, Yang XX, Xu WW, et al. Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China. Genet Mol Res 2012;11:4330–4341.
- Xu F, Zhang G, Zou J. Observation of DNA methyltransferase-3A and 3B gene single nucleotide polymorphism of patients with colorectal cancer. Shandong Med J 2013;53:15–18.
- Yang XX, He XQ, Li FX, et al. Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the southern chinese population. Int J Mol Sci 2012;13:8364–8378.
- Zhao C, Yan F, Wu H, et al. DNMT3A -448A>G polymorphism and the risk for hepatocellular carcinoma. Biomed Rep 2013;1:664–668.
- Zhao Z, Li C, Song Y, et al. Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer. Oncol Lett 2012;3:450–454.
- Tang W, Qiu H, Jiang H, et al. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects. PloS One 2014;9:e90328.
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj 2003;327:557–560.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
- Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–748.
- Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457–463.
- Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003;63:1114–1121.
- Fuks F, Burgers WA, Godin N, et al. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 2001;20:2536–2544.
- Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C–>A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999;8: 1443–1449.
- Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol 2009;578:3–22.
- Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol 2000;183:145–154.
- Shen H, Wang L, Spitz MR, et al. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 2002;62:4992–4995.